The U.S. Food and Drug Administration announced on 9 Nov that an emergency use authorization (EUA) has been issued for a rapid, single-use test for the detection of Ebola virus ( Zaire [Read more]
Current progress and future opportunities in applications of bioinformatics for biodefense and pathogen detection: report from the Winter Mid-Atlantic Microbiome Meet-up, College Park, MD, January 10, 2018 This article was originally published [Read more]
Chembio Diagnostics, Inc., a point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, this week reported financial results for the third quarter ended September 30, 2018. The company’s patented DPP® technology [Read more]
The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA) will sponsor the advanced development of [Read more]
The Naval Research Laboratory (NRL) is seeking partners to advance technology developed for in vitro diagnostic devices that are amenable to military hardening and integration with communication capabilities to support the medical [Read more]
To encourage the development and improvement of Infectious Diseases Next-Generation Sequencing (ID-NGS) analytical methods, precisionFDA – the community platform for NGS assay evaluation and regulatory science exploration – has launched the precisionFDA [Read more]
The U.S. Army is conducting market research to determine the feasibility of a competitive acquisition and to identify potential sources that can provide a Universal Mobile Tester (UMT) for the military’s Joint [Read more]
Illumina, Inc. announced on 15 May that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS). Edico Genome’s DRAGEN® Bio-IT Platform (DRAGEN) uses field programmable [Read more]
PATH and Mologic have announced a new agreement to work together to advance a rapid diagnostic test to support treatment and elimination of Plasmodium vivax. More than 2.5 billion people worldwide are at risk of [Read more]
The National Institute of Allergy and Infectious Diseases (NIAID) Division of AIDS (DAIDS) is seeking proposals from qualified offerors to provide a comprehensive quality assessment program for virologic assays for HIV, and [Read more]
© 2018 STEMAR MEDIA